Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Guardian Pharma (GRDN) Q3 2026 Earnings Call Transcript
Vice President, Investor Relations - Ashley Stockton President and Chief Executive Officer - Fred Burke Chief Operating Officer - David Morris Chief Financial Officer - Will Mudd Residents Served -- 218,000, representing 7% growth compared to the…
ARS Pharma (SPRY) Q3 2026 Earnings Call Transcript
President and Chief Executive Officer - Donn Casale Chief Commercial Officer - Meg Smith Chief Financial Officer - Kathleen Scott IR Representative - Monique Allaire Total Revenue -- $37.7 million, increasing from $32.5 million in the third quarter…
Nuvectis Pharma (NASDAQ:NVCT) Shares Up 12.5% - Still a Buy?
Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report)'s stock price rose 12.5% during mid-day trading on Friday. The company traded as high as $19.89 and last traded at $19.9810. Approximately 48,170 shares changed hands during mid-day trading, a…
Samvat 2082: Indian Markets Rebound, End Weakest Year in 15 on a High Note
Despite a challenging year marked by geopolitical tensions and foreign selling, Indian equity markets, including the Sensex and Nifty 50, staged a remarkable late recovery to end Samvat 2082 on a strong note, marking their weakest Samvat in 15…
RFK Jr. Stands 'FIRMLY BEHIND' Trump as Democrats Demand He Resign
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has made his position clear: he stands 'firmly behind' President Donald Trump and the 'historic reforms' the administration is advancing, according to a report from Breitbart. The…
How to predict the behavior of molecules from scant data
Discovering new molecules for specific uses is a major driver of progress in a wide variety of industries, whether it's pharmaceutical companies looking for new drugs, or electronics or energy companies seeking new materials with particular…
Intellia: Quiet Q3 Earnings As All Eyes Turn To March 2027 Approval Decision
Intellia Therapeutics approaches a pivotal FDA decision in March 2027 for lonvo-z, potentially the first in vivo CRISPR therapy for hereditary angioedema. Lonvo-z's Phase 3 data showed ~87% attack reduction and a clean safety profile, positioning…
Kohl's: Retailer Downgraded To Neutral Ahead Of Q3 Results, Awaiting Improved Earnings
Albert Anthony is the pen name of a business author on Amazon and a contributing analyst to investing platforms like Seeking Alpha since 2023, where he has over + 2,000 followers and has covered hundreds of stocks in multiple sectors including…
Novartis reports cases of tumours in children following treatment with Zolgensma
The treatment, hailed as a medical breakthrough in 2019, is now coming under scrutiny due to potential safety risks. Novartis said in a press release that nine reports of tumours in children treated with Zolgensma have been received since the…
Doximity outlines FY 2027 revenue of $678M-$683M as AI search reaches 8-figure bookings (NYSE:DOCS)
Earnings Call Insights: Doximity (DOCS) Q2 fiscal 2027 'Revenue was $175 million in Q2, up 4% year-over-year' (Co-Founder, CEO & Chairperson Jeffrey Tangney) and 'our Q2 adjusted EBITDA margin was 51% or $89 million' (CEO Tangney), alongside 'over…
URGENT: Yes, the Trump administration betrayed healthcare reform (and reformers)
Two years ago, Donald Trump entered office with a mandate to make major changes to American medicine — to limit the power of Big Pharma over the Food and Drug Administration, cut down on prescription drug advertising, give Americans more and…
Natera (NTRA) Q3 2026 Earnings Call Transcript
Chief Financial Officer - Michael Brophy Chief Executive Officer - Steven Leonard Chapman Chief Executive Officer - Solomon Moshkevich Total Revenues -- $794.0 million, growing 34.1% year over year driven by increased test volumes and improvements…
Mettler-Toledo (MTD) Q3 2026 Earnings Call Transcript
Head of Investor Relations - Adam William Uhlman Chief Executive Officer - Patrick K. Kaltenbach Chief Financial Officer - Shawn Vadala Net Sales -- $1.1 billion, representing 6% growth in reported and local currency terms driven by broad based…
Ziff Davis (ZD) Q3 2026 Earnings Call Transcript
Chief Executive Officer - Vivek R. Shah Chief Financial Officer - Bret Richter Revenue -- $289.3 million, reflecting a 5.6% decline year over year. Adjusted EBITDA -- $82.2 million, decreasing 16% from $97.8 million in the third quarter of 2025.
How wrecked GOP must rebuild, getting tired of 'winning' and other commentary
Conservative: How Wrecked GOP Must Rebuild The core cause of Tuesday's epic Republican losses is clear, explains Henry Olsen at The Washington Post: “Independents combined with a significant number of non-MAGA Republicans to reject the Trump…
Receive a Daily briefing on Pharma Industry News
Get Started